Vanguard Group Inc Biomarin Pharmaceutical Inc Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vanguard Group Inc holds 19,003,832 shares of BMRN stock, worth $1.08 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,003,832

Previous 19,003,212 -0.0%

Holding current value

$1.08 Billion

Previous $1.34 Billion 22.24%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$54.08 - $68.32 $33,529 - $42,358	620 Added 0.0%	19,003,832 $1.04 Billion
Q1 2025 May 09, 2025	SELL	$61.25 - $72.83 $22.6 Million - $26.9 Million	-368,973 Reduced 1.9%	19,003,212 $1.34 Billion
Q4 2024 Feb 11, 2025	BUY	$61.93 - $70.49 $5.79 Million - $6.59 Million	93,531 Added 0.49%	19,372,185 $1.27 Billion
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $19.6 Million - $26.7 Million	284,616 Added 1.5%	19,278,654 $1.36 Billion
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $65.3 Million - $80.9 Million	876,930 Added 4.84%	18,994,038 $1.56 Billion
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $5.62 Million - $6.64 Million	67,046 Added 0.37%	18,117,108 $1.58 Billion
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $26.6 Million - $34.4 Million	348,852 Added 1.97%	18,050,062 $1.74 Billion
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $3.44 Million - $3.83 Million	-40,496 Reduced 0.23%	17,701,210 $1.57 Billion
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $18.1 Million - $20.9 Million	208,460 Added 1.19%	17,741,706 $1.54 Billion
Q1 2023 Jul 14, 2023	BUY	$87.74 - $117.27 $131,610 - $175,905	1,500 Added 0.01%	17,533,246 $1.7 Billion
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $14.6 Million - $19.5 Million	166,666 Added 0.96%	17,531,746 $1.7 Billion
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $20.8 Million - $27.9 Million	256,791 Added 1.5%	17,365,080 $1.8 Billion
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $21.6 Million - $25.5 Million	263,453 Added 1.56%	17,108,289 $1.45 Billion
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $24.5 Million - $29.8 Million	342,593 Added 2.08%	16,844,836 $1.4 Billion
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $11.2 Million - $14 Million	151,212 Added 0.92%	16,502,243 $1.27 Billion
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $3.19 Million - $4.07 Million	44,474 Added 0.27%	16,351,031 $1.44 Billion
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $6.28 Million - $7.18 Million	83,963 Added 0.52%	16,306,557 $1.26 Billion
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $1.22 Billion - $1.38 Billion	16,222,594 New	16,222,594 $1.35 Billion

Others Institutions Holding BMRN

# of Institutions

673

Shares Held

185M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Biomarin Pharmaceutical Inc Transaction History